Literature DB >> 1909079

Immunohistological study on brains of Alzheimer's disease using antibodies to fetal antigens, C-series gangliosides and microtubule-associated protein 5.

H Takahashi1, K Hirokawa, S Ando, K Obata.   

Abstract

An immunohistological study of Alzheimer's brains was performed using antibodies to C-series gangliosides and microtubule-associated protein 5 (MAP5), and their staining patterns were compared with those of antibodies to tau and beta-amyloid precursor protein. Antibodies to C-series gangliosides and MAP5, both of which are known to preferentially expressed in the fetal brains, immunostained dystrophic neurites of senile plaques, neurofibrillary tangles and neuropil threads abundant in 3rd and 5th layers in the cerebral cortex, all of which are considered to be pathological hallmarks of Alzheimer's disease. The immunostaining patterns of these structures by antibodies to C-series gangliosides and MAP5 were similar to those by the antibody to tau. These three antibodies also immunostained some neurons in Alzheimer's brain, although their staining patterns were slightly different from one another; i.e., both diffuse and granular patterns were seen by the antibody to tau, but only granular pattern by the antibodies to C-series gangliosides and MAP5. These neurons immunostained by these three types of antibodies appeared to be the precursors of the classical neurofibrillary tangles, as positively stained neurons were not seen in the brains of non-demented cases. The presence of fetal antigens such as the C-series gangliosides and MAP5 in Alzheimer's brain may suggest that regeneration or sprouting of neurons is ongoing in association with the re-induction of gene expression characteristic for the brain in the early stage of development.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1909079     DOI: 10.1007/bf00296372

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  33 in total

1.  Microtubular reorganization and dendritic growth response in Alzheimer's disease.

Authors:  A C McKee; N W Kowall; K S Kosik
Journal:  Ann Neurol       Date:  1989-11       Impact factor: 10.422

2.  MAP5: a novel brain microtubule-associated protein under strong developmental regulation.

Authors:  B Riederer; R Cohen; A Matus
Journal:  J Neurocytol       Date:  1986-12

3.  Dendritic sprouting in Alzheimer's presenile dementia.

Authors:  A B Scheibel; U Tomiyasu
Journal:  Exp Neurol       Date:  1978-05-15       Impact factor: 5.330

4.  Alzheimer's disease brain extract stimulates the survival of cerebral cortical neurons from neonatal rats.

Authors:  Y Uchida; Y Ihara; M Tomonaga
Journal:  Biochem Biophys Res Commun       Date:  1988-02-15       Impact factor: 3.575

5.  The monoclonal antibody A2B5 is specific to ganglioside GQ1c.

Authors:  N Kasai; R K Yu
Journal:  Brain Res       Date:  1983-10-24       Impact factor: 3.252

6.  Immunohistological study of senile brains by using a monoclonal antibody recognizing beta amyloid precursor protein: significance of granular deposits in relation with senile plaques.

Authors:  H Takahashi; C Kurashima; M Utsuyama; K Hirokawa
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

7.  Alz 50, a monoclonal antibody to Alzheimer's disease antigen, cross-reacts with tau proteins from bovine and normal human brain.

Authors:  H Ksiezak-Reding; P Davies; S H Yen
Journal:  J Biol Chem       Date:  1988-06-15       Impact factor: 5.157

8.  Neuritic plaques in senile dementia of Alzheimer type: a Golgi analysis in the hippocampal region.

Authors:  A Probst; V Basler; B Bron; J Ulrich
Journal:  Brain Res       Date:  1983-06-06       Impact factor: 3.252

9.  Tau protein immunoreactivity in dementia of the Alzheimer type. I. Morphology, evolution, distribution, and pathogenetic implications.

Authors:  S C Papasozomenos
Journal:  Lab Invest       Date:  1989-01       Impact factor: 5.662

10.  Neuronal microtubule-associated proteins in the embryonic avian spinal cord.

Authors:  R P Tucker; L I Binder; A I Matus
Journal:  J Comp Neurol       Date:  1988-05-01       Impact factor: 3.215

View more
  8 in total

Review 1.  Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis.

Authors:  Norman J Haughey; Veera V R Bandaru; Mihyun Bae; Mark P Mattson
Journal:  Biochim Biophys Acta       Date:  2010-05-07

Review 2.  Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease--a review.

Authors:  Toshio Ariga; Michael P McDonald; Robert K Yu
Journal:  J Lipid Res       Date:  2008-03-11       Impact factor: 5.922

3.  GM1 inhibits amyloid beta-protein-induced cytokine release.

Authors:  T Ariga; R K Yu
Journal:  Neurochem Res       Date:  1999-02       Impact factor: 3.996

4.  C-series polysialogangliosides are expressed on stellate neurons of adult human cerebellum.

Authors:  M Heffer-Lauc; M Cacić; D Serman
Journal:  Glycoconj J       Date:  1998-04       Impact factor: 2.916

Review 5.  Neuronal dysfunction with aging and its amelioration.

Authors:  Susumu Ando
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2012       Impact factor: 3.493

6.  The pathological roles of ganglioside metabolism in Alzheimer's disease: effects of gangliosides on neurogenesis.

Authors:  Toshio Ariga; Chandramohan Wakade; Robert K Yu
Journal:  Int J Alzheimers Dis       Date:  2011-01-09

7.  Brain gangliosides of a transgenic mouse model of Alzheimer's disease with deficiency in GD3-synthase: expression of elevated levels of a cholinergic-specific ganglioside, GT1aα.

Authors:  Toshio Ariga; Yutaka Itokazu; Michael P McDonald; Yoshio Hirabayashi; Susumu Ando; Robert K Yu
Journal:  ASN Neuro       Date:  2013-05-30       Impact factor: 4.146

Review 8.  Gangliosides as Biomarkers of Human Brain Diseases: Trends in Discovery and Characterization by High-Performance Mass Spectrometry.

Authors:  Mirela Sarbu; Raluca Ica; Alina D Zamfir
Journal:  Int J Mol Sci       Date:  2022-01-08       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.